Logo

ZENITH DRUGS LIMITED Share Price

NSE: ZENITHDRUG
|
Pharmaceuticals
₹ 51.85
+₹1.00 (1.97%)
1D
Last updated 03 Jul, 2026, 15:19 IST

ZENITH DRUGS LIMITED Share Price Today

As of 5 Jul 2026, ZENITH DRUGS LIMITED share price is ₹51.85. The stock opened at ₹47.50, compared to its previous close of ₹50.85. During today's trading session, ZENITH DRUGS LIMITED share price moved in the range of ₹47.50 to ₹52.50, with an average price of ₹50.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹33.30 and a high of ₹78.95. On the performance front, ZENITH DRUGS LIMITED share price has increased by 0.10% over the last six months and is down 28.91% on a year-on-year basis.

₹47.50
1.97% up today
₹52.50
1D LOW
1D HIGH

ZENITH DRUGS LIMITED Returns Calculator

Open
₹47.50
High
₹52.50
Low
₹47.50
Prev. close
₹50.85
Circuit
L
H
₹40.95
₹61.35
52-week
L
H
₹33.30
₹78.95

ZENITH DRUGS LIMITED Shareholder Returns

ZENITH DRUGS LIMITED Share Price History

Mkt Cap Cr
107.52
P/E
11.22
P/B
1.73
ROE
24.13%
D/E
0.74
ROCE
25.16%
Div. Yield
0.00%
EPS(TTM)
2.30
Turnover
1.80
EV/EBITDA
6.95
Net Margin
0.00%
Op. Margin
0.00%
ROA
11.03%
Quick Ratio
0.00
Curr. Ratio
2.24
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Zenith Drugs outperforming all market indices
Step 3 of 5
Valuation
Fairly Valued
Zenith Drugs appears to be fairly valued compared to its peers
Step 3 of 5
Earnings
Neutral
Zenith Drugs earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,49,048.0039.025.3713.74%0.6117.33%93.240.85%0.5610.90
Divis Laboratories1,77,179.0069.0010.5715.32%0.0019.56%629.490.45%0.5898.19
Torrent Pharmaceuticals1,57,804.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,17,642.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Dr. Reddy's Laboratories1,12,368.0027.032.9711.07%0.1812.54%375.780.59%0.6338.68
Zydus Lifesciences1,10,651.0021.604.0818.59%0.3117.35%235.250.09%0.3935.38
Lupin1,09,676.0020.484.8923.76%0.0424.88%659.050.75%0.61129.18
Mankind Pharma1,02,729.0053.006.3011.74%0.3413.13%397.020.04%0.5449.37
Aurobindo Pharma90,608.0025.872.399.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,398.9060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

ZENITH DRUGS LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2024Mar 2023Mar 2022
Revenue₹131.62₹114.52₹91.66
Other Income₹2.12₹1.24₹1.01
Total Revenue₹133.74₹115.76₹92.67
Total Expenses₹119.00₹109.10₹88.26
Profit Before Tax₹13.44₹6.66₹4.41
Tax₹3.80₹1.78₹1.28
Profit After Tax₹9.65₹4.88₹3.13
EPS - Basic₹5.63₹122.02₹78.22
EPS - Diluted₹5.63₹122.02₹78.22

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2024Mar 2023Mar 2022
Profit before tax₹13.44₹6.66₹4.41
Income before WC changes₹17.74₹10.27₹7.87
Change in Assets-₹20.88-₹30.50-₹16.97
Change in Liabilities-₹5.84₹17.29₹15.57
Change in WC-₹26.72-₹13.22-₹1.40
Cash flow from Operations-₹13.01-₹4.77₹5.15
Cash flow from Investing₹26.00-₹0.27-₹5.24
Cash flow from Financing-₹4.47₹4.99₹1.24
Total Cash Flow₹8.52-₹0.05₹1.15
Cash (Start of the year)₹0.28₹0.33₹1.85
Cash (End of the year)₹8.80₹0.28₹3.00

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2024Mar 2023Mar 2022
Non-Current Assets₹21.71₹14.00₹15.05
Current Assets₹113.33₹83.92₹53.53
Total Assets₹135.04₹97.92₹68.58
Current Liabilities₹64.15₹71.65₹46.58
Net Current Asset₹49.18₹12.27₹6.95
Non-Current Liabilities₹8.56₹8.53₹9.90
Equity Capital₹62.33₹17.74₹12.11
Total Equity & Liabilities₹135.04₹97.92₹68.58

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹133.32₹131.62₹114.52₹91.66
Other Income₹2.61₹2.12₹1.24₹0.95
Total Revenue₹135.93₹133.74₹115.76₹92.60
Total Expenses₹126.42₹118.89₹109.10₹88.20
Profit Before Tax₹9.26₹13.29₹6.66₹4.40
Tax₹2.10₹3.76₹1.78₹1.19
Profit After Tax₹7.16₹9.54₹4.88₹3.21
EPS - Basic₹4.18₹5.56₹122.03₹80.32
EPS - Diluted₹4.18₹5.56₹122.03₹80.32

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹9.51₹13.29₹6.66₹4.40
Income before WC changes₹15.89₹17.59₹10.29₹7.87
Change in Assets-₹11.11-₹20.56-₹30.31-₹16.90
Change in Liabilities-₹4.49-₹5.88₹17.58₹15.18
Change in WC-₹15.60-₹26.44-₹12.73-₹1.72
Cash flow from Operations-₹5.47-₹15.84-₹4.27₹4.91
Cash flow from Investing-₹31.41-₹5.33-₹2.05-₹3.04
Cash flow from Financing₹28.39₹29.72₹6.30-₹0.83
Total Cash Flow-₹8.48₹8.55-₹0.01₹1.04
Cash (Start of the year)₹8.74₹0.20₹0.21₹1.85
Cash (End of the year)₹0.26₹8.74₹0.20₹2.89

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹46.30₹21.34₹13.14₹12.40
Current Assets₹115.18₹112.84₹84.08₹53.79
Total Assets₹161.48₹134.17₹97.22₹66.18
Current Liabilities₹79.30₹64.10₹71.65₹45.53
Net Current Asset₹35.87₹48.73₹12.43₹8.26
Non-Current Liabilities₹12.80₹7.85₹7.84₹7.81
Equity Capital₹69.38₹62.22₹17.73₹12.85
Total Equity & Liabilities₹161.48₹134.17₹97.22₹66.18
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
4
Neutral
3
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
69.57
Neutral
ATR (14)
2.55
Neutral
STOCH(9,6)
88.26
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
24.96
Bearish
UO(9)
66.63
Neutral
ROC(12)
24.45
Bullish
WillR(14)
-10.98
Bearish
Period
Simple value
Exponential vaue
5D
48.05
48.59
10D
45.95
46.76
20D
44.09
45.03
50D
42.62
43.67
100D
43.5
44.78

About ZENITH DRUGS LIMITED

ZENITH DRUGS LIMITED logo
ISIN
INE0QWN01013
Sector Market Cap
₹ 107.52 Cr

Zenith Drugs Ltd is an India-based pharmaceutical company. The Company is mainly engaged in the business of manufacturing and trading of medicine. The Company offers a range of formulations in various forms, such as ORS powder, liquid oral, ointments, creams, gels and liquid externals, capsules, tablets. Its liquid oral products include Aceclofenac & Paracetamol Suspension; Albendazole Oral Suspension BP 25 mg/ml; Ambroxol Hydrochloride & Levocetirizine Dihydrochloride Syrup; Bromhexine Hydrochloride Syrup 4mg/5ml; Cetirizine Dihydrochloride and AmbroxolHydrochloride Syrup; Cetirizine Dihydrochloride and AmbroxolHydrochloride Syrup; Chlorphenamine, Ammonium Chloride and Sodium Citrate Syrup; Chlorpheniramine Maleate Oral Solution USP 2 mg / 5 ml, and others. Its ointment products include Cetrimide Cream BP 0.5% w/w, Chloroxylenol Cream 0.8% w/w, Ciprofloxacin Cream 0.5% w/w, Ciprofloxacin with Fluocinolone & Clotrimazole Cream and others.

ZENITH DRUGS LIMITED Financial Highlights

  • Revenue: ZENITH DRUGS LIMITED reported revenue of ₹133.74 crore in FY24 vs ₹115.76 crore in FY23. It showed an increase of 15.53% on a yearly basis.
  • Operating Profit: ZENITH DRUGS LIMITED reported an operating profit of ₹14.74 crore in FY24 vs ₹6.66 crore in FY23. It showed an increase of 121.32% on a year-on-year basis.
  • Net Profit: ZENITH DRUGS LIMITED reported a net profit of ₹9.65 crore in FY24 vs ₹4.88 crore in FY23. It showed an increase of 97.75% on a yearly basis.
Know more
Promoters
69.98%
FII
0.00%
Other DII
0.00%
Retail and other
30.02%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
ZENITH DRUGS LIMITED logo
ZENITH DRUGS LIMITED
Pharmaceuticals
Add Stock
Add Another

FAQs on ZENITH DRUGS LIMITED Share Price